Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Neto, F
These injections are self-administered at home using prefilled pens or devices
The injectable form was placed on the FDA's Category 2 bulk drug substances list in 2023, restricting compounding pharmacies from preparing it under Section 503A
These medications slow gastric emptying and reduce gut motility, leading to harder stools and difficulty passing bowel movements
EC50 values were determined by 4-parameter non-logistical fit analysis
Costs remain a major barrier, particularly for semaglutide and tirzepatide, while liraglutide has become more affordable since its patent expired
US$ 28.71
US$ 23.81
US$ 28.41
US$ 23.26
US$ 28.24
US$ 22.51
US$ 25.79
US$ 26.22
US$ 27.41
